EichorEICHOR
Condition: Trilaciclib Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Trilaciclib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06714383Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06569459Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
Phase 1 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07490236A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patie
Phase 2 · 1 location(s) · Fudan University · NCT06699472A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer
Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06151262Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Phase 4 · 1 location(s) · Pharmacosmos A/S · NCT05874401Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06929936Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06698692Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Phase 2 · 1 location(s) · Hunan Cancer Hospital · NCT06752798Study of Trilaciclib and Lurbinectidin
Phase 2 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05578326Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Phase 3 · 1 location(s) · Pharmacosmos A/S · NCT07473128A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06569485Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
Phase 2 · 1 location(s) · wang shusen · NCT05978648Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06992739Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Tr
Phase 2 · 1 location(s) · Shanghai Chest Hospital · NCT06698965
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.